[1]霍然,李俊毅,陈丽妹,等.2016-2020年肿瘤患者铜绿假单胞菌感染及耐药趋势分析[J].福建医药杂志,2023,45(01):19-22.
　HUO Ran,LI Junyi,CHEN Limei,et al.Retrospective study of pseudomonas aeruginosa infection and drug resistance in tumor patients from 2016 to 2020[J].FUJIAN MEDICAL JOURNAL,2023,45(01):19-22.
点击复制

2016-2020年肿瘤患者铜绿假单胞菌感染及耐药趋势分析()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
45
期数:
2023年01期
页码:
19-22
栏目:
临床研究
出版日期:
2023-02-15

文章信息/Info

Title:
Retrospective study of pseudomonas aeruginosa infection and drug resistance in tumor patients from 2016 to 2020
文章编号:
1002-2600(2023)01-0019-04
作者:
霍然; 李俊毅1; 陈丽妹; 辛娜; 陈岩松; 陈燕2
福建医科大学肿瘤临床医学院 福建省肿瘤医院(福州 350014)
Author(s):
HUO Ran;  LI Junyi;  CHEN Limei;  XIN Na;  CHEN Yansong;  CHEN Yan
Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian 350001, China
关键词:
铜绿假单胞菌;  肿瘤患者;  耐药性;  抗生素
Keywords:
pseudomonas aeruginosa;  tumor patient;  antibiotic resistance;  antibiotics
分类号:
R378
文献标志码:
B
摘要:
目的 探讨肿瘤患者感染铜绿假单胞菌(PA)的临床分布、耐药趋势,为肿瘤患者PA感染治疗提供依据。方法 回顾性分析2016-2020年我院临床标本分离出PA的肿瘤患者的临床资料及药敏试验数据。结果 2016年1月至2020年12月我院共分离出PA 926株,临床患者标本来源主要为呼吸道标本(65.12%)。2016—2020年我院PA对亚胺培南的总体耐药率为31.42%,对美罗培南的总体耐药率为23.11%,对庆大霉素、环丙沙星、头孢他啶的总体耐药率分别为8.74%、16.41%、15.23%,对头孢吡肟、左氧氟沙星、哌拉西林、哌拉西林/他唑巴坦的总体耐药率分别为10.48%、13.39%、12.20%、11.12%。我院PA分离率与细菌耐药监测官网(CHINET网,http://www.chinets.com)监测数据差异无统计学意义(P>0.05); 但对亚胺培南耐药率高于CHINET监测数据,对左氧氟沙星、头孢吡肟、哌拉西林、哌拉西林/他唑巴坦耐药率低于CHINET监测数据(均P<0.05)。结论 PA是我院内检出率较高的条件致病菌之一,应高度警惕耐药菌株的产生。我院PA对常用抗生素耐药呈下降趋势; 但对于某些抗生素耐药性高于同一时期CHINET监测数据。临床工作中应密切监测肿瘤患者PA感染及耐药情况,同时在治疗中合理使用抗菌药物,预防耐药菌株的产生。
Abstract:
Objective To explore the clinical distribution and drug resistance trend of pseudomonas aeruginosa(PA) infection in tumor patients, and to provide evidence for the treatment of PA infection in tumor patients.Methods Clinical data and drug sensitivity test data on tumor patients with PA isolated from clinical specimens in our hospital from 2016 to 2020 were analyzed retrospectively.Results A total of 926 PA were detected from Jan.2016 to Dec.2020.The specimens were mainly from respiratory tract(65.12%).From 2016 to 2020, the overall drug resistance rate of PA in our hospital to imipenem was 31.42% and the overall drug resistance rate to meropenem was 23.11%.The overall drug resistance rates to gentamicin, ciprofloxacin and ceftazidime were 8.74%, 16.41% and 15.23%, respectively.There was no significant difference between the isolated rate of PA from our hospital and data on the official website of bacterial resistance monitoring(CHINET, http://www.chinets.com), while the drug resistance rate to imipenem is higher than that of CHINET data and the drug resistance rate to levofloxacin, cefepime, piperacillin, piperacillin/tazobactam were all lower than the data on CHINET.Conclusion We should be highly alert to the emergence of drug-resistant strains because PA was one of the conditional pathogens with high detection rate in our hospital.The resistance of PA isolated from our hosptial to common antibiotics was declining but the drug resistance to some antibiotics was higher than that of CHINET in the same period.In clinical work, we should monitor the PA infection and drug resistance in tumor patients closely, and at the same time, we should use antibiotics reasonably to prevent the emergence of drug resistant strains in the treatment of PA infection.

参考文献/References:

[1] 杨春琳, 王红波, 李菁, 等.细菌耐药率与抗菌药物使用情况的相关性分析[J].中国生化药物杂志, 2017, 37(5): 399-402.
[2] Pang Z, Raudonis R, Glick B R, et al.Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies[J].Biotechnol Adv, 2019, 37(1): 177-192.
[3] 张国栋, 王莹, 朱红胜.临床分离的美罗培南和环丙沙星共同耐药的铜绿假单胞菌耐药机制的研究[J].检验医学, 2014, 29(6): 646-650.
[4] 宋皓月, 黄凯峰, 汤荣, 等.2014—2017年上海市某医院铜绿假单胞菌不同耐药性菌株的临床分布[J].中国感染控制杂志, 2019, 18(12): 1093-1098.
[5] Dias V C, Resende J A, Bastos A N, et al.Epidemiological, Physiological, and molecular characteristics of a Brazilian collection of carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa[J].Microb Drug Resist, 2017, 23(7): 852-863.
[6] 胡方芳,张华,季萍, 等.中国西部地区2016-2017年下呼吸道标本分离细菌的分布及耐药性[J].中国抗生素杂志, 2018, 43(9): 1089-1094.
[7] Yang P, Chen Y, Jiang S, et al.Association between antibiotic consumption and the rate of carbapenem-resistant Gramnegative bacteria from China based on 153 tertiary hospitals data in 2014[J].Antimicrob Resist Infect Control, 2018,(7): 137.
[8] 陈泳伍, 张圣雨, 鲁怀伟, 等.碳青霉烯类抗菌药物专档管理对碳青霉烯类抗菌药物使用强度影响及CRO检出率相关分析[J].中国医院药学杂志, 2019, 39(16): 1678-1681.
[9] 王晓坤, 丁菊英.2012-2017年度东营地区临床常见非发酵菌耐药率变化及与抗菌药物使用量的相关性[J].山东医药, 2018, 58(23): 89-91.

相似文献/References:

[1]高世华 池细俤 李国玉 吴文辉.2013—2017年耐碳青霉烯类铜绿假单胞菌感染情况调查及 耐药性变迁[J].福建医药杂志,2018,40(06):35.
　GAO Shihua,CHI Xidi,LI Guoyu,et al.Investigation on the prevalence and drug resistance of CRPA from 2013 to 2017[J].FUJIAN MEDICAL JOURNAL,2018,40(01):35.

备注/Memo

备注/Memo:
1 福建医科大学医学技术与工程学院; 2 通信作者,Email:yanc99@sina.com
更新日期/Last Update: 2023-02-15